Market Cap 14.84M
Revenue (ttm) 15.03M
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.12%
Debt to Equity Ratio 0.00
Volume 54,100
Avg Vol 121,596
Day's Range N/A - N/A
Shares Out 5.89M
Stochastic %K 89%
Beta 7.31
Analysts Sell
Price Target $5.85

Latest News on VVOS

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:31 PM EST - 5 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 2:05 PM EDT - 9 months ago

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript


Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Closes $4 Million Private Placement


Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Reverse Stock Split